ALDX Stock Analysis: Buy, Sell, or Hold?
ALDX - Aldeyra Therapeutics, Inc.
$1.68
-0.09 (-5.08%)
▼
5d:
-24.66%
30d:
-69.23%
90d:
-68.36%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 13, 2026
Smart Money Accumulation
ALDX is down 3.0% this week, but smart money is accumulating calls. Top strike: $2 2026-06-18 with 484 OI. Call ratio: 85% View Scanner →
Strength: 5.0/10
Get Alerted When ALDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ALDX is down 24.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ALDX is down 24.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALDX is currently trading at $1.68, which is considered oversold relative to its 30-day fair value range of $2.25 to $5.45. From a valuation perspective, the stock is trading at a discount (Forward PE: -6.5) compared to its historical average (12.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ALDX is in a downtrend. Immediate support is located at $1.07, while resistance sits at $2.33. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.50 (+346.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALDX is in a downtrend. Immediate support is located at $1.07, while resistance sits at $2.33. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.50 (+346.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.25 -
$5.45
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-5.1%)
- BULLISH: Trading 346.4% below Wall St target ($7.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to -24.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.25 -
$5.45
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.07
Resistance Level
$2.33
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.52
Wall Street Target
$7.50
(+346.4%)
PE vs Historical
-6.5 vs 12.8
CHEAP
Share & Embed Analysis
Last updated: March 31, 2026 3:01 AM ET
Data refreshes hourly during market hours. Next update: 4:01 AM
Data refreshes hourly during market hours. Next update: 4:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 63 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 56 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 59 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 57 HOLD |
